---
schema_version: "secwatch.filing_event.v1"
accession: "0001808805-25-000082"
form_type: "8-K"
ticker: "NAUT"
cik: "0001808805"
company_name: "Nautilus Biotechnology, Inc."
filed_at: "2025-11-04T23:59:59+00:00"
generated_at: "2026-05-17T00:41:06.197087+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Nautilus regains Nasdaq minimum bid price compliance; deficiency closed

## Summary
- Received notice on Nov 3, 2025 that closing bid price met $1 for 10 consecutive days.
- Deficiency previously disclosed May 2, 2025; compliance period extended to April 27, 2026.
- Company transferred to Nasdaq Capital Market on Oct 29, 2025 to utilize second compliance period.
- Matter now closed; no further action required.

## SEC filing metadata
- accession: 0001808805-25-000082
- form_type: 8-K
- ticker: NAUT
- cik: 0001808805
- company_name: Nautilus Biotechnology, Inc.
- filed_at: 2025-11-04T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808805/000180880525000082/0001808805-25-000082-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808805/000180880525000082/naut-20251103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001808805-25-000082
- JSON: https://secwatch.observer/filing/0001808805-25-000082.json
- Plain text: https://secwatch.observer/filing/0001808805-25-000082.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.